Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study
Title: | Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study |
---|---|
Authors: | van Ramshorst, Mette S., van Werkhoven, Erik, Honkoop, Aafke H., Dezentjé, Vincent O., Oving, Irma M., Mandjes, Ingrid A., Kemper, Inge, Smorenburg, Carolien H., Stouthard, Jacqueline M., Linn, Sabine C., Sonke, Gabe S. |
Source: | In The Breast October 2016 29:153-159 |
Database: | ScienceDirect |
ISSN: | 09609776 |
---|---|
DOI: | 10.1016/j.breast.2016.07.017 |
Published in: | The Breast |
Language: | English |